SCHEMBL21848992

SCHEMBL21848992

CCc1cnn(C2CC2)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.38
DRD4 P21917 2/20 0.38
DRD3 P35462 2/20 0.38
ALOX15 P16050 1/20 0.38
CNR2 P34972 1/20 0.36
PDE1A P54750 2/20 0.34
PDE1B Q01064 2/20 0.34
PDE1C Q14123 2/20 0.34
PKM P14618 1/20 0.33
HPGD P15428 2/20 0.33
PLAT P00750 1/20 0.33
PDE9A O76083 1/20 0.32
TDP2 O95551 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22789246 0.79 CNR2 (0.35) ALOX15CNR2PDE1APDE1BPDE1C
SCHEMBL21863548 0.75 ALOX15 (0.50) DRD2DRD4DRD3ALOX15CNR2
SCHEMBL26341709 0.72 ALOX15 (0.40) DRD2DRD4DRD3ALOX15PDE1A
SCHEMBL26343962 0.72 ALOX15 (0.40) DRD2DRD4DRD3ALOX15PDE1A
SCHEMBL23275182 0.72 ALOX15 (0.47) DRD2DRD4DRD3ALOX15PDE1A
SCHEMBL25354294 0.72 ALOX15 (0.40) DRD2DRD4DRD3ALOX15CNR2
SCHEMBL21958547 0.72 GRM1 (0.38) PDE1APDE1BPDE1CPDE9AALDH1A1
SCHEMBL21816121 0.70 NOTUM (0.49) DRD2DRD4DRD3ALOX15ALDH1A1
SCHEMBL21849257 0.69 HCRTR1 (0.38) DRD2DRD4DRD3ALOX15CYP1A2
SCHEMBL19203134 0.69 ALOX15 (0.38) DRD2DRD4DRD3ALOX15PDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200102311-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2020-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200102311-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP DRD2 559/4885DRD4 1614/4885DRD3 803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.